The GHSG Approach to Treating Hodgkin's Lymphoma. - Wikidata - awgldk - TriplyDB

The GHSG Approach to Treating Hodgkin's Lymphoma.

The GHSG Approach to Treating Hodgkin's Lymphoma.

http://www.wikidata.org/entity/Q38506223

about

The GHSG Approach to Treating Hodgkin's Lymphoma.

http://www.wikidata.org/entity/Q38506223

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The GHSG Approach to Treating Hodgkin's Lymphoma.

@en

type

label

The GHSG Approach to Treating Hodgkin's Lymphoma.

@en

prefLabel

The GHSG Approach to Treating Hodgkin's Lymphoma.

@en

P1433

Q38506223-248DEDA9-9CF2-4191-9F21-19B5573D3F4D

P1476

Q38506223-D7887779-4637-4E5C-B745-7C3793AF7CB4

P2093

Q38506223-8948A1D5-11A6-4179-9D10-1FC786FB075E

Q38506223-CE484CB6-BC3E-4812-B472-4B26F7942A73

P2860

Q38506223-020B77A9-A4E4-4C21-96A2-8BD071A4C887

Q38506223-05437FDC-A1CA-4F9A-A01F-8CCAFFD71DF1

Q38506223-0BA92F48-9402-4723-B4A2-7649722A507A

Q38506223-1854F657-588A-45D0-96CE-F3F74F55737E

Q38506223-186E439B-03FF-40E7-886D-0D0648595E6C

Q38506223-259D6D61-58D6-47D2-93C4-6A627CC4BAA5

Q38506223-295DC44F-954F-483B-90B6-2CC6D473718A

Q38506223-2AF17291-F7DA-4854-9E91-53B32C6121E7

Q38506223-2B4D73AE-8158-4668-B70F-B9F845004259

Q38506223-2D3FC5E0-0E8B-4935-A81D-157B0F975610

P2888

Q38506223-24E0B2C1-4183-49AB-9B86-8AAEE4279EF0

P304

Q38506223-D8A69FEA-5741-4D71-BE59-705436C10A1B

P31

Q38506223-55226D16-BD5C-44A3-A067-810E238BC154

P356

Q38506223-BCF050B7-5960-450C-9148-B3E47D1C486A

P433

Q38506223-680849E0-8F10-465A-B9CF-1A72806D8697

P478

Q38506223-308D855A-C8E1-47F0-9A29-5BAF03C0F3FF

P577

Q38506223-B89C6D49-589A-45E7-9E68-40F15A50238E

P6179

Q38506223-3D37265C-BB1B-4A5D-B326-AFA7C64958FC

P698

Q38506223-D0D39366-5115-4343-B073-34AED258739D

P356

S11899-015-0262-5

P1433

Current hematologic malignancy reports

P1476

The GHSG Approach to Treating Hodgkin's Lymphoma.

@en

P2093

Andreas Engert

http://www.w3.org/2001/XMLSchema#string

Paul J Bröckelmann

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.

Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.

Hodgkin lymphoma: an update on its biology with new insights into classification.

Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms.

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

P2888

s11899-015-0262-5

P304

256-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11899-015-0262-5

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020501557

http://www.w3.org/2001/XMLSchema#string

P698

26021610

http://www.w3.org/2001/XMLSchema#string